More than 65,438+0,000 employees of the group company (including close subsidiaries) strive to realize the integration, intensification, chain and diversification of pharmaceutical products. The group company is one of the top 50 enterprises in total profit and tax of pharmaceutical business in China, a national "GSP standard enterprise", a provincial-level "civilized unit" in Zhejiang Province, the first batch of large-scale commercial enterprises in Zhejiang Province, the "Top Ten Enterprises" in pharmaceutical business in Zhejiang Province, the "Best Economic Benefit Enterprise" in Wenzhou City, the "Customer Satisfaction Unit in Zhejiang Market" awarded by China Market Research Center, and the AAA enterprise with quality and service reputation in China. 1999 was awarded as "Excellent Political Research Association" by Zhejiang Workers' Ideological and Political Work Research Association. "1996-2005 national outstanding enterprises in ideological and political work in pharmaceutical industry" and "1996-2005 national outstanding political research society in pharmaceutical industry".
In 2006, we experienced the impact of bidding storm, price reduction storm, drug supervision storm, bribery storm and procuratorial storm, overcame difficulties, and in the midst of difficulties, Qi Xin made concerted efforts to increase revenue and reduce expenditure, and finally completed various tasks assigned by superiors. In 2006, the total sales of pharmaceutical products of our group company was 350 million yuan, slightly lower than 354 million yuan in 2005 (the absolute amount was reduced due to the price reduction of drugs); Profit 1.08 million yuan, slightly increased compared with 1.06 million yuan in 2005; The total tax payment was 4,644,500 yuan, and the asset preservation rate increased by 1. 1.5%. In mid-2006, it was awarded the honorary titles of "Top 100 Enterprises in Wenzhou", AAA-level enterprise in credit supervision and evaluation, advanced unit in Wenzhou credit enterprise and A-level unit in labor security credit.